Across the recent three months, 4 analysts have shared their insights on Alphatec Holdings (NASDAQ:ATEC), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 2 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Alphatec Holdings, presenting an average target of $18.75, a high estimate of $23.00, and a low estimate of $16.00. This current average represents a 11.76% decrease from the previous average price target of $21.25.
Diving into Analyst Ratings: An In-Depth Exploration
The analysis of recent analyst actions sheds light on the perception of Alphatec Holdings by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Drew Ranieri | Morgan Stanley | Lowers | Overweight | $16.00 | $19.00 |
| Mathew Blackman | Stifel | Lowers | Buy | $19.00 | $24.00 |
| David Saxon | Needham | Maintains | Buy | $23.00 | $23.00 |
| Matthew O'Brien | Piper Sandler | Lowers | Overweight | $17.00 | $19.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Alphatec Holdings. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Alphatec Holdings compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Alphatec Holdings's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Alphatec Holdings's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Alphatec Holdings analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
All You Need to Know About Alphatec Holdings
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Understanding the Numbers: Alphatec Holdings's Finances
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Positive Revenue Trend: Examining Alphatec Holdings's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 26.91% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Alphatec Holdings's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -35.02%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Alphatec Holdings's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -83.85%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Alphatec Holdings's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -6.14%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 14.4, Alphatec Holdings faces challenges in effectively managing its debt levels, indicating potential financial strain.
The Significance of Analyst Ratings Explained
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.